Meihua International Medical Technologies Co., Ltd.
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- 0.4
- Dividend yield
- –
About Meihua International Medical Technologies
Surgical & Medical Instruments & Apparatus, SIC 3841
Meihua International Medical Technologies Co., Ltd. is a provider and distributor of disposable medical devices. Operating primarily through Chinese subsidiaries, the company manufactures and sells Class I, Class II, and Class III disposable medical devices under its proprietary brands, while also distributing products sourced from third-party manufacturers. Its product portfolio includes non-bottled items such as brushes and identification bracelets, as well as polyethylene bottled goods like eye drop bottles and tablet containers. In addition, the organization maintains operations dedicated to medical technology trading, import-export facilitation, and software-as-a-service development. Its customer base consists of domestic and overseas clients.
The company's primary operating subsidiaries are located in Yangzhou within Jiangsu Province, and Qionghai City within Hainan Province, People's Republic of China, alongside a software services entity established in New York, United States. Its principal executive offices are headquartered in Yangzhou, Jiangsu Province, China.
Summary of the business section of Meihua International Medical Technologies's latest annual report, written by StockData.
Company profile
Company
- Legal name
- Meihua International Medical Technologies Co., Ltd.
- Founded
- 2020
- Headquarters
- Yangzhou, F4
- Address
- 88 Tongda Road, Touqiao Town, Guangling District 225000
- Phone
- (86) 0514-89800199
- Website
- meihuamed.com
- Employees
- 69, Dec 31, 2025
- Industry
- Surgical & Medical Instruments & Apparatus
- Incorporated in
- E9
- Fiscal year ends
- December 31
- Auditor
- LI CPA LLC, Aurora, Colorado
Stock & identifiers
- Ticker
- MHUAF
- Exchange
- OTC
- IPO date
- Feb 17, 2022
- Shares outstanding
- 1M, Dec 31, 2025
- Filer category
- Non-accelerated filer<br>Emerging growth company
- Stock splits
- 1-for-100 reverse, Apr 29, 2026; 1-for-100 reverse, Nov 24, 2025
- SEC CIK
- 1835615
- EIN
- 00-0000000
Executives and directors
Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years
| Name | Position | Shares owned |
|---|---|---|
| Ailiang Wang | Chairwoman | – |
| Shilong Liao | CFO | – |
| Anna Colin | Independent Director | – |
| Chongbo Gao | Independent Director | – |
| Leyi Lee | CEO | – |
| Wenzhang Jia | Director | – |
Employees
Headcount reported in annual reports
“device industry, we have a professional R&D Talents team comprised of 69 employees as of the date of this Annual Report, who have”
Corporate history
Events identified from SEC filings
| Date | Event | Details |
|---|---|---|
| Apr 29, 2022 | Late filing | Notification of late filing |
| Feb 17, 2022 | IPO | Initial public offering priced (424B4 prospectus) |
| Feb 15, 2022 | Listing | Registration of securities on an exchange (Form 8-A) |